Elevated vascular resistance after labetalol during resection of a pheochromocytoma (Brief report)

Peter C.H. Chung*, Allen H. Li, Chih Chung Lin, Ming Wen Yang

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

20 Scopus citations

Abstract

Purpose: To report a case of pheochromocytoma exhibiting an increase in systemic vascular resistance index (SVRI) and decreased cardiac index (CI) after use of labetalol. Clinical features: A 36-yr-old male underwent adrenectomy for pheochromocytoma. Midazolam 5 mg, fentanyl 100 μg and labetalol 20 mg were administrated intravenously for premedication upon arrival in the operating theatre. After induction of anesthesia with fentanyl, thiopental and atracurium, 30 mg iv labetalol was administered. The blood pressure gradually rose to 178/101 mmHg with mildly increased SVRI (1958 dn-sec-1·mcm5) and stable CI (3.8 L·min-1·m2). The blood pressure reached 247/150 mmHg after intubation with an increase in SVRI (3458 20 mg. Sodium nitroprusside was administered and the blood pressure declined immediately to 108/72 mmHg, with a decreased SVRI (2526 dn-sec-1·m2·cm5) and stable CI (2.3 L·min-1·m2). [[Conclusions: The elevated SVRI with low CI was considered to result from increased α-adrenergic activity secondary to β-adrenergic blockade with labetalol. Clinicians should be aware of the possibility of a hypertensive crisis after iv labetalol. We suggest that labetalol should be replaced promptly with α-adrenergic blockers or other vasodilators when such a condition arises.

Original languageEnglish
Pages (from-to)148-150
Number of pages3
JournalCanadian Journal of Anesthesia
Volume49
Issue number2
DOIs
StatePublished - 2002
Externally publishedYes

Fingerprint

Dive into the research topics of 'Elevated vascular resistance after labetalol during resection of a pheochromocytoma (Brief report)'. Together they form a unique fingerprint.

Cite this